Abstract：Objective: To explore the regulatory role of B-cell activating factor (BAFF) on the balance of helper T cell 17 (Th17) and regulatory T cell (Treg) in vivo in a mouse model of immune thrombocytopenia (ITP).Methods: Guinea pig anti-mouse platelet serum (GP-APS) was prepared, and 150 adult male BALB/c mice (7-8 weeks old) were randomly divided into 5 groups (n=30 per group): control (blank control), ITP (induced by GP-APS), ITP+rhBAFF (ITP mice treated with intravenous injection of recombinant human BAFF protein at 50μg/kg/50μL), ITP+rhBAFF+DAPT (combined with Notch1 inhibitor DAPT), and ITP+rhBAFF+PGD (combined with PI3K/Akt inhibitor Polygalacin D). DAPT was injected at 100μg/kg, and PGD at 25 μg/kg, both with a total volume of 50μL and administered once daily. Peripheral blood (1mL) was collected from mice after 1 week for serum and mononuclear cell isolation. Immunofluorescence staining was used to detect BAFF and Notch1 localization in mononuclear cells. Platelet counts in peripheral blood were determined. Enzyme-linked immunosorbent assay (ELISA) was performed to measure BAFF levels in mouse serum. Western blotting was conducted to assess protein expression of PI3K, AKT, Notch1, p-Akt(Thr308), and p-Akt(Ser473) in mononuclear cells. Flow cytometry was used to analyze changes in Th17/Treg ratio in mononuclear cells.Results: BAFF and Notch1 were co-localized on the cell membrane of mononuclear cells in peripheral blood of ITP mice. Compared with the control group, ITP group showed increased expression of BAFF, Notch1, p-Akt(Thr308), p-Akt(Ser473), increased Th17 proportion, decreased platelet count, and decreased Treg proportion (P<0.05). Compared with the ITP group, ITP+rhBAFF group exhibited increased BAFF, Notch1, p-Akt(Thr308), p-Akt(Ser473) expression, increased Th17 proportion, decreased platelet count, and decreased Treg proportion (P<0.05). Compared with the ITP+rhBAFF group, both ITP+rhBAFF+DAPT and ITP+rhBAFF+PGD groups showed decreased BAFF, Notch1, p-Akt(Thr308), p-Akt(Ser473) expression, increased platelet count, increased Treg proportion, and decreased Th17 proportion (P<0.05).Conclusion: BAFF promotes an increase in Th17 proportion and decrease in Treg proportion in a mouse model of immune thrombocytopenia by activating the Notch1/PI3K/Akt signaling pathway.
李巍, 马西虎, 刘晓, 费飞, 秦兰, 买尔吾甫·木合布力, 白玉盛. BAFF调节免疫性血小板减少症模型小鼠的Th17/Treg平衡的研究[J]. 河北医学, 2024, 30(8): 1267-1272.
LI Wei, MA Xihu, LIU Xiao, et al. Regulation of Th17/Treg Balance by BAFF in a Mouse Model of Immune Thrombocytopenia. HeBei Med, 2024, 30(8): 1267-1272.
[1] Gonzalez-Lopez Tj,Provan D,Barez A,et al.Primary and secondary immune thrombocytopenia (ITP):Time for a rethink[J].Blood Rev,2023(61):101112.
[2] Kargar M,Torabizadeh M,Purrahman D,et al.Regulatory factors involved in Th17/Treg cell balance of immune thrombocytopenia[J].Curr Res Transl Med,2023,71(2):103389.
[3] Wang D,Cassady K,Zou Z,et al.Progress on the efficacy and potential mechanisms of rapamycin in the treatment of immune thrombocytopenia[J].Hematology,2022,27(1):1282-1289.
[4] Xu P,Shao X,Ou Y,et al.Neutrophils contribute to elevated BAFF levels to modulate adaptive immunity in patients with primary immune thrombocytopenia by CD62P and PSGL1 interaction[J].Clin Transl Immunology,2022,11(7):1399.
[5] Jia W,Poe Jc,Su H,et al.BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantation[J].Blood,2021,137(18):2544-2557.
[6] Desouza S,Angelini D.Updated guidelines for immune thrombocytopenic purpura:expanded management options[J].Cleve Clin Med,2021,88(12):664-668.
[7] Lin Y,Zhu X,Li Y,et al.LY294002 ameliorates psoriatic skin inflammation in mice via blocking the Notch1/Hes1-PTEN/AKT/IL-17A feedback loop[J].Clinical and experimental immunology,2023,213(1):114-124.
[8] Cheng J,Wang S,Lv Sq,et al.Resveratrol inhibits AhR/Notch axis and reverses Th17/Treg imbalance in purpura by activating Foxp3[J].Toxicol Res,2023,12(3):381-391.
2024, Vol. 30 
冀公网安备13080202000677号